AngioDynamics ROE 2010-2024 | ANGO
Current and historical return on equity (ROE) values for AngioDynamics (ANGO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| AngioDynamics ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-08-31 | $-0.24B | $0.20B | -95.01% |
| 2024-05-31 | $-0.18B | $0.21B | -58.69% |
| 2024-02-29 | $-0.19B | $0.22B | -53.86% |
| 2023-11-30 | $-0.01B | $0.40B | -3.24% |
| 2023-08-31 | $0.01B | $0.43B | 1.99% |
| 2023-05-31 | $-0.05B | $0.38B | -12.77% |
| 2023-02-28 | $-0.04B | $0.40B | -8.76% |
| 2022-11-30 | $-0.03B | $0.41B | -7.64% |
| 2022-08-31 | $-0.03B | $0.41B | -7.53% |
| 2022-05-31 | $-0.03B | $0.42B | -6.04% |
| 2022-02-28 | $-0.04B | $0.43B | -8.98% |
| 2021-11-30 | $-0.04B | $0.43B | -8.63% |
| 2021-08-31 | $-0.03B | $0.44B | -7.62% |
| 2021-05-31 | $-0.03B | $0.44B | -6.88% |
| 2021-02-28 | $-0.17B | $0.46B | -37.16% |
| 2020-11-30 | $-0.17B | $0.45B | -34.65% |
| 2020-08-31 | $-0.17B | $0.46B | -31.87% |
| 2020-05-31 | $-0.17B | $0.46B | -29.13% |
| 2020-02-29 | $0.05B | $0.61B | 7.99% |
| 2019-11-30 | $0.06B | $0.61B | 9.35% |
| 2019-08-31 | $0.06B | $0.61B | 10.46% |
| 2019-05-31 | $0.06B | $0.62B | 10.95% |
| 2019-02-28 | $0.01B | $0.55B | 0.91% |
| 2018-11-30 | $0.02B | $0.55B | 3.31% |
| 2018-08-31 | $0.02B | $0.55B | 2.98% |
| 2018-05-31 | $0.02B | $0.54B | 3.02% |
| 2018-02-28 | $0.00B | $0.54B | 0.19% |
| 2017-11-30 | $-0.01B | $0.52B | -1.92% |
| 2017-08-31 | $0.00B | $0.52B | 0.77% |
| 2017-05-31 | $0.01B | $0.52B | 0.96% |
| 2017-02-28 | $-0.03B | $0.53B | -4.82% |
| 2016-11-30 | $-0.03B | $0.52B | -5.16% |
| 2016-08-31 | $-0.04B | $0.51B | -7.74% |
| 2016-05-31 | $-0.04B | $0.51B | -7.99% |
| 2016-02-29 | $-0.00B | $0.55B | -0.18% |
| 2015-11-30 | $-0.01B | $0.55B | -1.10% |
| 2015-08-31 | $-0.01B | $0.55B | -0.92% |
| 2015-05-31 | $-0.00B | $0.55B | -0.74% |
| 2015-02-28 | $-0.01B | $0.54B | -0.92% |
| 2014-11-30 | $0.00B | $0.54B | 0.74% |
| 2014-08-31 | $0.00B | $0.54B | 0.56% |
| 2014-05-31 | $0.00B | $0.54B | 0.56% |
| 2014-02-28 | $0.00B | $0.54B | 0.75% |
| 2013-11-30 | $-0.00B | $0.53B | -0.38% |
| 2013-08-31 | $0.00B | $0.53B | 0.00% |
| 2013-05-31 | $-0.00B | $0.53B | -0.19% |
| 2013-02-28 | $-0.01B | $0.53B | -1.33% |
| 2012-11-30 | $-0.01B | $0.53B | -1.61% |
| 2012-08-31 | $-0.01B | $0.52B | -1.71% |
| 2012-05-31 | $-0.01B | $0.52B | -1.37% |
| 2012-02-29 | $0.00B | $0.41B | 0.00% |
| 2011-11-30 | $0.01B | $0.41B | 1.47% |
| 2011-08-31 | $0.01B | $0.41B | 1.73% |
| 2011-05-31 | $0.01B | $0.41B | 1.99% |
| 2011-02-28 | $0.01B | $0.41B | 3.27% |
| 2010-11-30 | $0.01B | $0.40B | 3.05% |
| 2010-08-31 | $0.01B | $0.40B | 3.09% |
| 2010-05-31 | $0.01B | $0.39B | 3.13% |
| 2010-02-28 | $0.01B | $0.39B | 2.90% |
| 2009-11-30 | $0.01B | $0.38B | 2.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.278B | $0.304B |
| AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies and Vascular Access. Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products and Venous Insufficiency. The Thrombus Management portfolio includes the proprietary AngioVac venous drainage cannula and circuit as well as catheter directed thrombolytic devices. Vascular Access arm offers advanced imaging equipment to guide the placement of catheters that primarily deliver short-term drug therapies. IGVA procedures include the placement of Peripherally Inserted Central Catheters lines, implantable ports and central venous catheters. Oncology/Surgery division includes Microwave Ablation, Radiofrequency Ablation and NanoKnife product lines. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $196.322B | 23.95 |
| Intuitive Surgical (ISRG) | United States | $195.140B | 102.02 |
| Alcon (ALC) | Switzerland | $42.414B | 28.38 |
| Edwards Lifesciences (EW) | United States | $41.569B | 26.40 |
| IQVIA Holdings (IQV) | United States | $36.630B | 20.18 |
| IDEXX Laboratories (IDXX) | United States | $34.166B | 40.24 |
| DexCom (DXCM) | United States | $28.447B | 42.84 |
| Waters (WAT) | United States | $22.175B | 32.79 |
| STERIS (STE) | Ireland | $21.157B | 24.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.795B | 0.00 |
| Hologic (HOLX) | United States | $18.343B | 19.35 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.004B | 13.35 |
| Sysmex ADR (SSMXY) | Japan | $12.946B | 0.00 |
| Globus Medical (GMED) | United States | $11.536B | 29.21 |
| Penumbra (PEN) | United States | $9.397B | 92.04 |
| Masimo (MASI) | United States | $9.260B | 44.81 |
| Teleflex (TFX) | United States | $8.904B | 14.20 |
| Glaukos (GKOS) | United States | $7.940B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.884B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.632B | 26.26 |
| Veracyte (VCYT) | United States | $3.068B | 92.07 |
| Inari Medical (NARI) | United States | $2.907B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.787B | 16.09 |
| TransMedics (TMDX) | United States | $2.552B | 80.89 |
| Nihon Kohden (NHNKY) | Japan | $2.480B | 18.84 |
| Elekta AB (EKTAY) | Sweden | $2.167B | 17.66 |
| Tandem Diabetes Care (TNDM) | United States | $2.023B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.820B | 9.51 |
| RxSight (RXST) | United States | $1.807B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.427B | 0.00 |
| Artivion (AORT) | United States | $1.185B | 78.53 |
| Pulse Biosciences (PLSE) | United States | $1.088B | 0.00 |
| OPKO Health (OPK) | United States | $1.078B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.855B | 14.53 |
| Paragon 28 (FNA) | United States | $0.841B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.723B | 0.00 |
| IRadimed (IRMD) | United States | $0.675B | 36.46 |
| OrthoPediatrics (KIDS) | United States | $0.638B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.593B | 13.97 |
| AxoGen (AXGN) | United States | $0.587B | 0.00 |
| SiBone (SIBN) | United States | $0.527B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.493B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.488B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.463B | 31.05 |
| Tactile Systems Technology (TCMD) | United States | $0.428B | 23.18 |
| CVRx (CVRX) | United States | $0.360B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.326B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.312B | 0.00 |
| NeuroPace (NPCE) | United States | $0.290B | 0.00 |
| Inogen (INGN) | United States | $0.223B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.204B | 0.00 |
| Accuray (ARAY) | United States | $0.194B | 0.00 |
| Nevro (NVRO) | United States | $0.169B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.162B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.146B | 15.60 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| 908 Devices (MASS) | United States | $0.089B | 0.00 |
| LENSAR (LNSR) | United States | $0.086B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.084B | 0.00 |
| Hyperfine (HYPR) | United States | $0.074B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.068B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.049B | 0.00 |
| Envoy Medical (COCH) | United States | $0.044B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.041B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Neuronetics (STIM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Spectral AI (MDAI) | United States | $0.022B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |